Product description
Symbol | Cusip | Name | Amount | Value | Title Of Class | Pay of profile | |
---|---|---|---|---|---|---|---|
03828A101 | 03828A101 | Applied Therapeutics, Inc. | 1575654.0 | 3781569.6 | CORP | Long | |
N/A | N/A | Applied Therapeutics, Inc. | 1008400.0 | 2420160.0 | CORP | Long | |
03770N101 | 03770N101 | Apogee Therapeutics, Inc. | 163539.0 | 2809600.02 | CORP | Long | |
427746102 | 427746102 | Heron Therapeutics, Inc. | 1195377.0 | 761335.61 | CORP | Long | |
68622P109 | 68622P109 | ORIC Pharmaceuticals, Inc. | 234001.0 | 1567806.7 | CORP | Long | |
00445A100 | 00445A100 | ACELYRIN, Inc. | 257390.0 | 2621517.15 | CORP | Long | |
09061G101 | 09061G101 | BioMarin Pharmaceutical, Inc. | 110289.0 | 8983039.05 | CORP | Long | |
75974E103 | 75974E103 | Reneo Pharmaceuticals, Inc. | 473833.0 | 3833308.97 | CORP | Long | |
75525N107 | 75525N107 | RayzeBio, Inc. | 126900.0 | 2461860.0 | CORP | Long | |
N/A | N/A | Merus NV | 499426.0 | 10043456.86 | CORP | Long | |
N/A | N/A | Jazz Pharmaceuticals plc | 219463.0 | 27876190.26 | CORP | Long | |
282559103 | 282559103 | 89bio, Inc. | 254237.0 | 1881353.8 | CORP | Long | |
03237H101 | 03237H101 | Amylyx Pharmaceuticals, Inc. | 224524.0 | 3661986.44 | CORP | Long | |
603170101 | 603170101 | Mineralys Therapeutics, Inc. | 143600.0 | 1110028.0 | CORP | Long | |
64125C109 | 64125C109 | Neurocrine Biosciences, Inc. | 177673.0 | 19711042.62 | CORP | Long | |
457669307 | 457669307 | Insmed, Inc. | 720116.0 | 18046106.96 | CORP | Long | |
26818M108 | 26818M108 | Dyne Therapeutics, Inc. | 355434.0 | 2505809.7 | CORP | Long | |
09062X103 | 09062X103 | Biogen, Inc. | 152922.0 | 36325091.88 | CORP | Long | |
08205P126 | 08205P126 | Benitec Biopharma, Inc. | 7019473.0 | 118601.02 | CORP | Long | |
50127T109 | 50127T109 | Kura Oncology, Inc. | 178292.0 | 1506567.4 | CORP | Long | |
729139105 | 729139105 | Pliant Therapeutics, Inc. | 300500.0 | 4408335.0 | CORP | Long | |
N/A | N/A | Sartorius AG | 9200.0 | 2305668.84 | CORP | Long | |
08205P209 | 08205P209 | Benitec Biopharma, Inc. | 364887.0 | 1320890.94 | CORP | Long | |
04016X101 | 04016X101 | Argenx SE | 47485.0 | 22297531.45 | CORP | Long | |
N/A | N/A | Applied Therapeutics, Inc. | 1628100.0 | 2318017.14 | CORP | Long | |
46116X101 | 46116X101 | Intra-Cellular Therapies, Inc. | 442216.0 | 22004668.16 | CORP | Long | |
254604101 | 254604101 | Disc Medicine, Inc. | 50325.0 | 2305388.25 | CORP | Long | |
N/A | N/A | Roivant Sciences Ltd. | 274573.0 | 2372310.72 | CORP | Long | |
02083G100 | 02083G100 | Alpine Immune Sciences, Inc. | 203381.0 | 2082621.44 | CORP | Long | |
23282W605 | 23282W605 | Cytokinetics, Inc. | 232424.0 | 8102300.64 | CORP | Long | |
869367102 | 869367102 | Sutro Biopharma, Inc. | 564189.0 | 1551519.75 | CORP | Long | |
452327109 | 452327109 | Illumina, Inc. | 117900.0 | 12900618.0 | CORP | Long | |
N/A | N/A | Pipeline Therapeutics, Inc. | 1651505.0 | 3237484.89 | CORP | Long | |
23954D109 | 23954D109 | Day One Biopharmaceuticals, Inc. | 908581.0 | 10748513.23 | CORP | Long | |
152309100 | 152309100 | Centessa Pharmaceuticals plc | 89257.0 | 586418.49 | CORP | Long | |
98420N105 | 98420N105 | Xenon Pharmaceuticals, Inc. | 55051.0 | 1706581.0 | CORP | Long | |
230031106 | 230031106 | Cullinan Oncology, Inc. | 680120.0 | 6345519.6 | CORP | Long | |
69366J200 | 69366J200 | PTC Therapeutics, Inc. | 295864.0 | 5547450.0 | CORP | Long | |
90400D108 | 90400D108 | Ultragenyx Pharmaceutical, Inc. | 60696.0 | 2148638.4 | CORP | Long | |
670703107 | 670703107 | Nuvalent, Inc. | 45289.0 | 2359104.01 | CORP | Long | |
604749101 | 604749101 | Mirum Pharmaceuticals, Inc. | 236190.0 | 6478691.7 | CORP | Long | |
29446K106 | 29446K106 | Equillium, Inc. | 259471.0 | 129735.5 | CORP | Long | |
046353108 | 046353108 | AstraZeneca plc | 451308.0 | 28536204.84 | CORP | Long | |
803607100 | 803607100 | Sarepta Therapeutics, Inc. | 66852.0 | 4499808.12 | CORP | Long | |
03969K108 | 03969K108 | Arcutis Biotherapeutics, Inc. | 1288820.0 | 2899845.0 | CORP | Long | |
N/A | N/A | Carmot Therapeutics, Inc. | 83100.0 | 1363793.9 | CORP | Long | |
67080N119 | 67080N119 | Nuvation Bio, Inc. | 115266.0 | 4610.64 | CORP | Long | |
00370M103 | 00370M103 | Abivax SA | 269100.0 | 2475720.0 | CORP | Long | |
92243G108 | 92243G108 | Vaxcyte, Inc. | 176239.0 | 8477095.9 | CORP | Long | |
492327101 | 492327101 | Keros Therapeutics, Inc. | 189651.0 | 5412639.54 | CORP | Long | |
04351P101 | 04351P101 | Ascendis Pharma A/S | 309111.0 | 27606703.41 | CORP | Long | |
877619106 | 877619106 | Taysha Gene Therapies, Inc. | 243880.0 | 570679.2 | CORP | Long | |
23257D103 | 23257D103 | Cymabay Therapeutics, Inc. | 775553.0 | 12703558.14 | CORP | Long | |
22663K107 | 22663K107 | Crinetics Pharmaceuticals, Inc. | 43322.0 | 1268901.38 | CORP | Long | |
014442107 | 014442107 | Alector, Inc. | 303345.0 | 1577394.0 | CORP | Long | |
N/A | N/A | Harpoon Therapeutics, Inc. | 430500.0 | 2024511.49 | CORP | Long | |
032724106 | 032724106 | AnaptysBio, Inc. | 105463.0 | 1720101.53 | CORP | Long | |
49372L100 | 49372L100 | Kezar Life Sciences, Inc. | 449150.0 | 323882.07 | CORP | Long | |
56854Q200 | 56854Q200 | Marinus Pharmaceuticals, Inc. | 1200781.0 | 8333420.14 | CORP | Long | |
92532F100 | 92532F100 | Vertex Pharmaceuticals, Inc. | 146635.0 | 53097999.85 | CORP | Long | |
82835W108 | 82835W108 | ARS Pharmaceuticals, Inc. | 1229989.0 | 4391060.73 | CORP | Long | |
761330109 | 761330109 | Revance Therapeutics, Inc. | 845760.0 | 6673046.4 | CORP | Long | |
52490G102 | 52490G102 | Legend Biotech Corp. | 122034.0 | 8062786.38 | CORP | Long | |
48576A100 | 48576A100 | Karuna Therapeutics, Inc. | 38051.0 | 6339677.11 | CORP | Long | |
00509G209 | 00509G209 | Acumen Pharmaceuticals, Inc. | 491900.0 | 919853.0 | CORP | Long | |
8611239C3 | 8611239C3 | Institutional Fiduciary Trust Money Market Portfolio | 10068485.0 | 10068485.0 | RF | Long | |
41358P205 | 41358P205 | Harpoon Therapeutics, Inc. | 44529.0 | 224426.16 | CORP | Long | |
43157M102 | 43157M102 | HilleVax, Inc. | 575656.0 | 6332216.0 | CORP | Long | |
30233G209 | 30233G209 | EyePoint Pharmaceuticals, Inc. | 783533.0 | 4716868.66 | CORP | Long | |
N/A | N/A | Aeglea BioTherapeutics, Inc. | 5500.0 | 2406396.58 | CORP | Long | |
152309100 | 152309100 | Centessa Pharmaceuticals plc | 189736.0 | 1246565.52 | CORP | Long | |
77313F106 | 77313F106 | Rocket Pharmaceuticals, Inc. | 217526.0 | 3937220.6 | CORP | Long | |
031162100 | 031162100 | Amgen, Inc. | 228082.0 | 58320567.4 | CORP | Long | |
N/A | N/A | Applied Therapeutics, Inc. | 814000.0 | 1953518.6 | CORP | Long | |
05352A100 | 05352A100 | Avantor, Inc. | 450529.0 | 7852720.47 | CORP | Long | |
137404109 | 137404109 | Candel Therapeutics, Inc. | 383376.0 | 345000.06 | CORP | Long | |
75886F107 | 75886F107 | Regeneron Pharmaceuticals, Inc. | 65833.0 | 51342498.37 | CORP | Long | |
N/A | N/A | Harpoon Therapeutics, Inc. | 215250.0 | 352443.89 | CORP | Long | |
375558103 | 375558103 | Gilead Sciences, Inc. | 420314.0 | 33011461.56 | CORP | Long | |
883556102 | 883556102 | Thermo Fisher Scientific, Inc. | 22679.0 | 10086938.83 | CORP | Long | |
40131M109 | 40131M109 | Guardant Health, Inc. | 173066.0 | 4478948.08 | CORP | Long | |
81181C104 | 81181C104 | Seagen, Inc. | 103566.0 | 22039880.46 | CORP | Long | |
N/A | N/A | Benitec Biopharma, Inc. | 310881.0 | 237992.77 | CORP | Long | |
471871103 | 471871103 | Jasper Therapeutics, Inc. | 1439300.0 | 983761.55 | CORP | Long | |
N/A | N/A | Artiva Biotherapeutics, Inc. | 189499.0 | 645750.25 | CORP | Long | |
86366E106 | 86366E106 | Structure Therapeutics, Inc. | 80210.0 | 5959603.0 | CORP | Long | |
457756500 | 457756500 | Institutional Fiduciary Trust - Money Market Portfolio | 15217134.61 | 15217134.61 | RF | Long | |
148806102 | 148806102 | Catalent, Inc. | 22700.0 | 780653.0 | CORP | Long | |
N/A | N/A | Sanofi SA | 2333755.0 | 0.0 | CORP | Long | |
N/A | N/A | Structure Therapeutics, Inc. | 103899.0 | 2400850.4 | CORP | Long | |
N/A | N/A | Benitec Biopharma, Inc. | 310881.0 | 1125358.13 | CORP | Long | |
61559X104 | 61559X104 | MoonLake Immunotherapeutics | 67535.0 | 3498988.35 | CORP | Long | |
880881107 | 880881107 | Terns Pharmaceuticals, Inc. | 682684.0 | 3590917.84 | CORP | Long |